We are live on
!
Find out more
ITP
Iron Triangle Partners Portfolio holdings
AUM
$875M
1-Year Est. Return
49.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.07%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
–
AUM
$697M
AUM Growth
-$274M
(-28%)
Cap. Flow
-$284M
Cap. Flow
% of AUM
-40.76%
Top 10 Holdings %
Top 10 Hldgs %
63.57%
Holding
35
New
9
Increased
6
Reduced
11
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$45M |
| 2 |
Envista
NVST
|
+$24M |
| 3 |
HCA Healthcare
HCA
|
+$23.8M |
| 4 |
Boston Scientific
BSX
|
+$22.1M |
| 5 |
Acadia Healthcare
ACHC
|
+$20.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Waters Corp
WAT
|
+$58.8M |
| 2 |
Charles River Laboratories
CRL
|
+$45.9M |
| 3 |
Encompass Health
EHC
|
+$44M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$43.5M |
| 5 |
Intuitive Surgical
ISRG
|
+$40.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLGC
26
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $3.95M | 0.57% |
+318,662
| New | +$3.59M |
|
|
27
Encompass Health
EHC
$11.3B
| – | – |
-708,454
| Closed | -$44M |
|
28
Idexx Laboratories
IDXX
$43.9B
| – | – |
-50,000
| Closed | -$31.6M |
|
29
Pulmonx
LUNG
$51.5M
| – | – |
-550,000
| Closed | -$24.3M |
|
30
Pacific Biosciences
PACB
$422M
| – | – |
-976,245
| Closed | -$34.1M |
|
|
31
Waters Corp
WAT
$36.4B
| – | – |
-169,999
| Closed | -$58.8M |
|
32
Zimmer Biomet
ZBH
$17.8B
| – | – |
-221,598
| Closed | -$34.6M |
|
|
DMTK
33
DELISTED
DermTech, Inc. Common Stock
DMTK
| – | – |
-250,000
| Closed | -$10.4M |
|
|
CANO
34
DELISTED
Cano Health, Inc.
CANO
| – | – |
-9,000
| Closed | -$10.9M |
|
|
OSH
35
DELISTED
Oak Street Health, Inc.
OSH
| – | – |
-535,528
| Closed | -$31.4M |
|
Similar funds
8KM
MFG
NP
GGI
WFAL
OBWP
TWM
AGC
Iron Triangle Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Iron Triangle Partners held 35 positions worth $697M, down 28% from $971M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Iron Triangle Partners withdrew a net $284M in Q3 2021, closing 9 positions and reducing 11 holdings. Its most notable exit was Waters Corp, an estimated $58.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier.
Against the trend, Iron Triangle Partners opened a new position in Hologic worth $44.3M.
- Iron Triangle Partners's largest Q3 2021 buy was Hologic: 600,000 shares worth $44.3M.
- Iron Triangle Partners added most to Envista in Q3 2021, an estimated $24M increase.
- Iron Triangle Partners's biggest Q3 2021 reduction was Charles River Laboratories, cutting an estimated $45.9M.
- Iron Triangle Partners fully exited Waters Corp in Q3 2021, selling an estimated $58.8M.
- Iron Triangle Partners's ten largest holdings make up 64% of its $697M portfolio in Q3 2021.
- Iron Triangle Partners opened 9 new positions and closed 9 in Q3 2021.
- Iron Triangle Partners's portfolio value fell 28% quarter-over-quarter to $697M.
Based on Iron Triangle Partners's 13F filing for Q3 2021, filed 15 Nov 2021.